OR4G4P

Across TCGA pan-cancer cohorts, OR4G4P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated OR4G4P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR4G4P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR4G4P expression acts as an unfavorable survival marker.

STAD, PAAD, and SARC are the cancer types where OR4G4P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.052	0.496	<.001	36	view →
PAAD	DFS	Tertile	II,III,IV	0.129	0.454	<.001	36	view →
SARC	DFS	Tertile	All	0.069	0.632	<.001	36	view →
ESCA	DFS	Tertile	III,IV	0.133	0.447	.019	18	view →
TGCT	OS	Tertile	All	0.814	0.967	.020	18	view →
LGG	OS	Tertile	All	0.173	0.799	<.001	18	view →
SKCM	DFS	Tertile	III,IV	0.058	0.648	.001	9	view →
PCPG	DFS	Tertile	All	0.112	0.849	.037	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

OR4G4P–STAD (OS)

Open the STAD breakdown →